Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis

In April 2017 midostaurin was approved by the US Food and Drug Administration for the treatment of patients with aggressive systemic mastocytosis (ASM). So far, very limited real world data on its efficacy is available. Thirteen patients aged from 48 to 79 years, who received midostaurin in the earl...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Clin Med
Main Authors: Szudy-Szczyrek, Aneta, Bachanek-Mitura, Oliwia, Gromek, Tomasz, Chromik, Karolina, Mital, Andrzej, Szczyrek, Michał, Krupski, Witold, Szumiło, Justyna, Kanduła, Zuzanna, Helbig, Grzegorz, Hus, Marek
格式: Artigo
語言:Inglês
出版: MDPI 2021
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7961806/
https://ncbi.nlm.nih.gov/pubmed/33799933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10051109
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍